GLYCOPHOS

Product NDC
65219-348
Requested package NDC
65219-348-10
11-digit product format
652190348
Labeler code
65219
Product ID
65219-348_05761514-5960-44b8-8e1d-7f0a1ceeee2a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sodium Glycerophosphate
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Fresenius Kabi USA, LLC
Application
NDA220381
Marketing category
NDA
Marketing start
2026-07-29
Substance
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Active strength
216 mg/mL
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N220381-001GLYCOPHOSSODIUM GLYCEROPHOSPHATE4.32GM/20ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29
N220381-002GLYCOPHOSSODIUM GLYCEROPHOSPHATE21.6GM/100ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N220381-001GLYCOPHOS4.32GM/20ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29d4dbc9d85df4…
2026-11-14 07:37:172026-10N220381-002GLYCOPHOS21.6GM/100ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29d4dbc9d85df4…
2026-10-15 13:18:302026-09N220381-001GLYCOPHOS4.32GM/20ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29c2088c7a36db…
2026-10-15 13:18:302026-09N220381-002GLYCOPHOS21.6GM/100ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29c2088c7a36db…
2026-09-14 22:38:342026-08N220381-001GLYCOPHOS4.32GM/20ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-2984e616aacf4f…
2026-09-14 22:38:342026-08N220381-002GLYCOPHOS21.6GM/100ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-2984e616aacf4f…
2026-08-18 06:07:402026-07N220381-001GLYCOPHOS4.32GM/20ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29caaa826d4ba7…
2026-08-18 06:07:402026-07N220381-002GLYCOPHOS21.6GM/100ML (216MG/ML)SOLUTION / INTRAVENOUSRLD, RS2026-07-29caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
GLYCOPHOS
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SODIUM GLYCEROPHOSPHATE ANHYDROUS216 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
YP1H63LJ2KInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1423807Internal RxNorm lookup
1423812Internal RxNorm lookup
2754772Internal RxNorm lookup
2754775Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e887e473-f1a7-40f1-bd6e-c99e7db7420dAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GLYCOPHOSSODIUM GLYCEROPHOSPHATEFresenius Kabi USA, LLCe887e473-f1a7-40f1-bd6e-c99e7db7420d2026-10-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 220381
application number: NDA220381
ndc (package): 65219-348-10
ndc (product): 65219-348
ndc11 (package): 65219034810

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
65219-348-106521903481020 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-348-10) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (65219-348-01) 2026-07-29NoNoCurrent